Chemotherapy-related outcomes in triple-negative breast cancer.

被引：2
|
作者：
Wellmann, Rebecca M.
Ghafouri, Sanaz N.
McAndrew, Nicholas Patrick
Hurvitz, Sara A.
机构：
[1] Univ Calif Los Angeles, Dept Internal Med, Los Angeles, CA USA
[2] Univ Calif Los Angeles, Johnsson Comprehens Canc Ctr, Los Angeles, CA 90095 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2019年 / 37卷 / 15期
关键词：
D O I：
10.1200/JCO.2019.37.15_suppl.e12049
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e12049
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Comprehensive kinome activity mapping of triple-negative breast cancer.
    Koemans, Nina M.
    Van der Borden, Carolien L.
    Mori, Miki
    Pan, Bo
    Wang, Changjun
    Van 't Veer, Laura J.
    Coppe, Jean-Philippe
    MOLECULAR CANCER RESEARCH, 2018, 16 (08) : 44 - 44
  • [22] Lymphatic and vascular invasion patterns in triple-negative breast cancer.
    Yaman, S.
    Gumuskaya, B.
    Ozkan, C.
    Aksoy, S.
    Guler, G.
    Altundag, M. K.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [23] MYC as a therapeutic target for the treatment of triple-negative breast cancer.
    Foley, Sarah A.
    Casten, Alina
    Kavanagh, Emma
    Synnott, Naoise C.
    Crown, John
    Larsson, Lars-Gunnar
    Duffy, Michael J.
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [24] Distinct immune microenvironments stratify triple-negative breast cancer.
    Gruosso, Tina
    Kumar, Venkata Satya
    Gigoux, Mathieu
    Saleh, Sadiq
    Bertos, Nicholas
    Omeroglu, Atilla
    Zuo, Dongmei
    Meterissian, Sarkis
    Haibe-Kains, Benjamin
    Park, Morag
    MOLECULAR CANCER RESEARCH, 2018, 16 (08) : 17 - 17
  • [25] Targeting the RXR pathway for the prevention of triple-negative breast cancer.
    Moyer, Cassandra
    Hill, Jamal
    Coleman, Darian
    Sei, Shizuko
    Mohammed, Altaf
    Sanders, Martin
    Brown, Powel
    Mazumdar, Abhijit
    CANCER PREVENTION RESEARCH, 2023, 16 (01)
  • [26] Patterns of mutation enrichment in metastatic triple-negative breast cancer.
    Saravia, Cesar H.
    Flores, Claudio J.
    Schwarz, Luis Jesus
    Bravo, Leny
    Zavaleta, Jenny
    Araujo, Jhajaira M.
    Neciosup, Silvia P.
    Pinto, Joseph A.
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [27] Characterizing the gut microbiome of patients with triple-negative breast cancer.
    Swoboda, April T.
    Sharma, Anukriti
    Olopade, Olufunmilayo I.
    Nanda, Rita
    Gilbert, Jack
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [28] The prognostic impact of age in patients with triple-negative breast cancer.
    Liedtke, C.
    Gluz, D.
    Kiesel, L.
    Hortobagyi, G. N.
    Pusztai, L.
    Gonzalez-Angulo, A. M.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [29] ADAMs as new therapeutic targets for triple-negative breast cancer.
    Mullooly, M.
    McGowan, P. M.
    Sukor, S. U.
    Madden, S. F.
    McDermott, E.
    Crown, J.
    O'Donovan, N.
    Duffy, M. J.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [30] Expression of novel immunotherapeutic targets in triple-negative breast cancer.
    Basu, Gargi Dan
    Ghazalpour, Anatole
    Gatalica, Zoran
    Anderson, Karen S.
    McCullough, Ann E.
    Spetzer, David B.
    Pockaj, Barbara A.
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
12345